Chinese biotech Hutchmed today announces that the New Drug Application (NDA) for fanregratinib (HMPL-453) for the treatment of adult patients with advanced, metastatic or unresectable intrahepatic ...

As many people consider lifestyle changes at the start of the year, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is urging the public to make sure any weight-loss medicines they ...

Against the backdrop of a turbulent year marked by both breakthrough and setbacks, the biopharmaceutical industry is entering ...

The share of imported drugs in the Russian pharmaceutical market should significantly decline over the next six years, while ...

A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...